UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
---------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) of the SECURITIES EXCHANGE ACT OF 1934
Date of earliest event reported: October 21, 2003
WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified in charter)
Pennsylvania 1-8036 23-1210010
(State of Incorporation) (Commission File Number) (I.R.S. Employer
Identification No.)
101 Gordon Drive, P.O. Box 645, Lionville, Pennsylvania 19341-0645
(Address of Principal Executive Offices) (Zip Code)
(610) 594-2900
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
- --------------------------------------------------------------------------------
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits:
Exhibit # Description
99.1 West Pharmaceutical Services, Inc. Press Release,
dated October 21, 2003.
Item 9. Regulation FD Disclosure
The following information is furnished pursuant to Item 12,
"Disclosure of Results of Operations and Financial Condition."
On October 21, 2003 West Pharmaceutical Services, Inc.(the "Company")
issued a press release announcing the Company's third quarter
financial results for the quarter ended September 30, 2003. A copy
of the press release is attached hereto as Exhibit 99.1 and is
incorporated herein by reference.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
WEST PHARMACEUTICAL SERVICES, INC.
Date: October 21, 2003 By: /s/ William J. Federici
-------------------------------
William J. Federici
Vice President and
Chief Financial Officer
Exhibit Index
99.1 West Pharmaceutical Services, Inc. Press Release, dated October 21, 2003.
West Pharmaceutical Services (WST)
Filed: 21 Oct 03, 12:00am